MEDIA ADVISORY, Oct. 20, 2006 (PRIMEZONE) --
What: Dr. John R. Plachetka, Chairman, President and CEO of POZEN Inc. (POZN) will preside over the closing bell to celebrate its ten-year business anniversary and six-year listing anniversary. POZEN Inc. is a member of The NASDAQ Health Care Index and The NASDAQ Biotechnology Index. Where: NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio When: Monday October 23rd, 2006 at 4:00 p.m. EDT Contacts: Fran Barsky Director Investor Relations 919-913-1044 email@example.com NASDAQ MarketSite: Stephanie Lowenthal; 646.441.5220
The closing bell is available from 3:50 p.m. to 4:05 p.m. on uplink IA-6 C-band/transponder 17. The downlink frequency is 4040 Vertical; Audio 6.2-6.8. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Stephanie Lowenthal at (646) 441-5220.
To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.
About POZEN Inc. (POZN):
POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. POZEN's efforts are focused primarily on the development of pharmaceutical products for the treatment of acute and chronic pain and other pain-related conditions. POZEN has development and commercialization alliances with GlaxoSmithKline and AstraZeneca. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.
In This StoryNDAQ
Nasdaq Press Center
Read the latest press releases, request a press kit, and get in touch with our press team.